CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $349,720,051
- in 75 filings, $348.9M under 10b5-1 plans
Net −$349,720,051. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −373 | $576.16 | $215K | 333,570 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,017 | $577.14 | $587K | 332,553 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,763 | $578.17 | $1.0M | 330,790 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,127 | $579.11 | $653K | 329,663 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −955 | $580.13 | $554K | 328,708 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,112 | $581.18 | $646K | 327,596 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −449 | $582.57 | $262K | 327,147 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,004 | $583.22 | $1.2M | 325,143 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −381 | $584.22 | $223K | 324,762 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −79 | $585.27 | $46K | 324,683 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $586.49 | $141K | 324,443 |
| 2026-11-17 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −9,500 | 5,410 | ||
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −110 | $580.25 | $64K | 333,833 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −170 | $581.25 | $99K | 333,663 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $582.18 | $163K | 333,383 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $583.61 | $140K | 333,143 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $584.54 | $374K | 332,503 |
| 2026-11-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,382 | $585.83 | $810K | 331,121 |
Page 1 of 215 · 4,286 trades